Filing Details
- Accession Number:
- 0001328143-21-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-08 17:32:33
- Reporting Period:
- 2021-06-07
- Accepted Time:
- 2021-06-08 17:32:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1328143 | Adamas Pharmaceuticals Inc | ADMS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198230 | J Martha Demski | C/O Adamas Pharmaceuticals, Inc. 1900 Powell St., Suite 1000 Emeryville CA 94608 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-07 | 2,000 | $5.17 | 8,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,000 | Indirect | Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee |
Footnotes
- This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax obligations in connection with the vesting of the reporting person's director restricted stock awards.
Billionaire Hedge Funds
